MX2016000344A - Un conjugado de fc de inmunoglobulina que mantiene la afinidad de union del fragmento fc de inmunoglobulina hacia fcrn. - Google Patents

Un conjugado de fc de inmunoglobulina que mantiene la afinidad de union del fragmento fc de inmunoglobulina hacia fcrn.

Info

Publication number
MX2016000344A
MX2016000344A MX2016000344A MX2016000344A MX2016000344A MX 2016000344 A MX2016000344 A MX 2016000344A MX 2016000344 A MX2016000344 A MX 2016000344A MX 2016000344 A MX2016000344 A MX 2016000344A MX 2016000344 A MX2016000344 A MX 2016000344A
Authority
MX
Mexico
Prior art keywords
immunoglobulin
conjugate
binding strength
fragment
fcrn binding
Prior art date
Application number
MX2016000344A
Other languages
English (en)
Inventor
Se Chang Kwon
Sung Youb Jung
In Young Choi
Jong Soo Lee
Sung Hee Hong
Sang Youn Hwang
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of MX2016000344A publication Critical patent/MX2016000344A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Abstract

La presente invención se refiere a un conjugado de polipéptido fisiológicamente activo y fragmento Fc de inmunoglobulina que comprende un polipéptido fisiológicamente activo unido a través de un enlazador no peptídico a un fragmento Fc de inmunoglobulina que tiene una región de unión a FcRn y mantiene la afinidad de unión intrínseca del fragmento Fc de inmunoglobulina, un método de preparación del conjugado, un método de mantenimiento de la afinidad de unión intrínseca del conjugado hacia FcRn y una composición que comprende el conjugado que mantiene la afinidad de unión intrínseca del fragmento Fc de inmunoglobulina hacia FcRn.
MX2016000344A 2013-07-12 2014-07-14 Un conjugado de fc de inmunoglobulina que mantiene la afinidad de union del fragmento fc de inmunoglobulina hacia fcrn. MX2016000344A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20130082509 2013-07-12
PCT/KR2014/006328 WO2015005747A1 (ko) 2013-07-12 2014-07-14 FcRn 결합력이 유지되는 면역글로불린 Fc 결합체

Publications (1)

Publication Number Publication Date
MX2016000344A true MX2016000344A (es) 2016-05-05

Family

ID=52280325

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016000344A MX2016000344A (es) 2013-07-12 2014-07-14 Un conjugado de fc de inmunoglobulina que mantiene la afinidad de union del fragmento fc de inmunoglobulina hacia fcrn.

Country Status (22)

Country Link
US (2) US20160152684A1 (es)
EP (1) EP3020732B1 (es)
JP (2) JP2016525099A (es)
KR (2) KR101872559B1 (es)
CN (2) CN105593243A (es)
AR (1) AR096890A1 (es)
AU (1) AU2014287879B2 (es)
CA (1) CA2917838C (es)
DK (1) DK3020732T3 (es)
EA (1) EA034297B1 (es)
ES (1) ES2799326T3 (es)
HK (1) HK1221957A1 (es)
HU (1) HU231424B1 (es)
IL (1) IL243567B (es)
MX (1) MX2016000344A (es)
MY (1) MY180374A (es)
NO (1) NO20160182A1 (es)
PH (1) PH12016500111A1 (es)
PT (1) PT3020732T (es)
TW (1) TWI693236B (es)
UA (1) UA119644C2 (es)
WO (1) WO2015005747A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130049671A (ko) 2011-11-04 2013-05-14 한미사이언스 주식회사 생리활성 폴리펩타이드 결합체 제조 방법
AR090281A1 (es) 2012-03-08 2014-10-29 Hanmi Science Co Ltd Proceso mejorado para la preparacion de un complejo polipeptidico fisiologicamente activo
HU231358B1 (hu) * 2014-03-31 2023-03-28 Hanmi Pharm. Co., Ltd Eljárás fehérjék és peptidek oldhatóságának javítására immunoglobulin Fc fragmentum kapcsolás alkalmazása révén
AR107483A1 (es) * 2016-01-29 2018-05-02 Hanmi Pharm Ind Co Ltd Conjugado de enzimas terapéuticas
US20190352335A1 (en) * 2016-12-19 2019-11-21 Hanmi Pharm. Co., Ltd. Brain targeting long-acting protein conjugate
US20220273808A1 (en) * 2019-07-18 2022-09-01 Hanmi Pharm. Co., Ltd Novel method of preparing protein conjugate
KR102382593B1 (ko) * 2020-01-29 2022-04-05 고려대학교 산학협력단 pH-감응성 Fc 변이체

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6030613A (en) * 1995-01-17 2000-02-29 The Brigham And Women's Hospital, Inc. Receptor specific transepithelial transport of therapeutics
US6096871A (en) 1995-04-14 2000-08-01 Genentech, Inc. Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
EP0904107B1 (en) 1996-03-18 2004-10-20 Board Of Regents, The University Of Texas System Immunoglobin-like domains with increased half lives
UA91325C2 (ru) * 2002-12-26 2010-07-26 Маунтин Вью Фармасьютикалз, Инк. Полимерные конъюгаты цитокинов, хемокинов, факторов роста, полипептидных гормонов и их антагонистов с сохраненной активностью рецепторного связывания
US20050176108A1 (en) * 2003-03-13 2005-08-11 Young-Min Kim Physiologically active polypeptide conjugate having prolonged in vivo half-life
ES2378167T3 (es) * 2003-11-13 2012-04-09 Hanmi Holdings Co., Ltd Complejo de proteína que utiliza fragmento de inmunoglobulina y el método para su preparación
KR100609434B1 (ko) 2004-12-30 2006-08-03 한국항공우주연구원 트랜스버살 필터
KR100754667B1 (ko) * 2005-04-08 2007-09-03 한미약품 주식회사 비펩타이드성 중합체로 개질된 면역글로불린 Ｆｃ 단편 및이를 포함하는 약제학적 조성물
US7625564B2 (en) * 2006-01-27 2009-12-01 Novagen Holding Corporation Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
JP2008169195A (ja) * 2007-01-05 2008-07-24 Hanmi Pharmaceutical Co Ltd キャリア物質を用いたインスリン分泌ペプチド薬物結合体
KR20080098216A (ko) * 2007-05-04 2008-11-07 한미약품 주식회사 캐리어 물질을 이용한 나트륨 배설 펩타이드 약물 결합체
EP2162472B1 (en) * 2007-05-30 2013-02-27 Postech Academy-Industry- Foundation Immunoglobulin fusion proteins
JP2009019027A (ja) 2007-07-16 2009-01-29 Hanmi Pharmaceutical Co Ltd アミノ末端のアミノ酸が変異したインスリン分泌ペプチド誘導体
ES2523043T3 (es) * 2008-07-23 2014-11-20 Hanmi Science Co., Ltd. Un complejo polipeptídico que comprende un polímero no peptidílico que tiene tres extremos funcionales
EP2545079A2 (en) * 2010-03-11 2013-01-16 Rinat Neuroscience Corporation ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDING
AR081066A1 (es) * 2010-04-02 2012-06-06 Hanmi Holdings Co Ltd Conjugado de insulina donde se usa un fragmento de inmunoglobulina
KR101333958B1 (ko) * 2010-10-20 2013-11-27 주식회사 한독 인간 인터루킨-1 수용체 길항제-하이브리드 Ｆｃ 융합단백질
UA113626C2 (xx) * 2011-06-02 2017-02-27 Композиція для лікування діабету, що містить кон'югат інсуліну тривалої дії та кон'югат інсулінотропного пептиду тривалої дії
SG10201604564XA (en) 2011-06-10 2016-07-28 Hanmi Science Co Ltd Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
UA114709C2 (uk) * 2011-06-17 2017-07-25 Ханмі Сайенс Ко., Лтд. Кон'югат, що містить похідну оксинтомодуліну, fc-ділянку імуноглобуліну та непептидильний полімер, та його застосування
US9789202B2 (en) * 2011-09-05 2017-10-17 Hanmi Science Co., Ltd. Method for treating cancer using an interferon alpha conjugate
KR20130049671A (ko) * 2011-11-04 2013-05-14 한미사이언스 주식회사 생리활성 폴리펩타이드 결합체 제조 방법
KR102041412B1 (ko) * 2011-12-30 2019-11-11 한미사이언스 주식회사 면역글로불린 Ｆｃ 단편 유도체

Also Published As

Publication number Publication date
JP2016525099A (ja) 2016-08-22
EA201690114A1 (ru) 2016-07-29
MY180374A (en) 2020-11-28
IL243567B (en) 2020-11-30
JP6880278B2 (ja) 2021-06-02
KR20180071241A (ko) 2018-06-27
PT3020732T (pt) 2020-06-25
EP3020732B1 (en) 2020-03-18
KR20150008011A (ko) 2015-01-21
CN116082528A (zh) 2023-05-09
AU2014287879A1 (en) 2016-02-11
EA034297B1 (ru) 2020-01-27
NO20160182A1 (en) 2016-03-02
HK1221957A1 (zh) 2017-06-16
HU231424B1 (hu) 2023-08-28
TW201546093A (zh) 2015-12-16
KR101872559B1 (ko) 2018-06-28
EP3020732A4 (en) 2016-12-28
NZ716275A (en) 2021-09-24
AR096890A1 (es) 2016-02-03
TWI693236B (zh) 2020-05-11
PH12016500111A1 (en) 2016-04-18
EP3020732A1 (en) 2016-05-18
CA2917838A1 (en) 2015-01-15
AU2014287879B2 (en) 2020-01-02
UA119644C2 (uk) 2019-07-25
CN105593243A (zh) 2016-05-18
IL243567A0 (en) 2016-03-31
HUP1600206A2 (hu) 2016-05-30
CA2917838C (en) 2023-06-20
ES2799326T3 (es) 2020-12-16
KR102076718B1 (ko) 2020-02-12
DK3020732T3 (da) 2020-06-15
JP2020125337A (ja) 2020-08-20
WO2015005747A1 (ko) 2015-01-15
US20220380437A1 (en) 2022-12-01
US20160152684A1 (en) 2016-06-02

Similar Documents

Publication Publication Date Title
PH12016500111A1 (en) An immunoglobulin fc conjugate which maintains binding affinity of immunoglobulin fc fragment to fcrn
PH12020550205A1 (en) IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
CY1122978T1 (el) Αντισωματα εναντι-vla-4
MX2015006548A (es) Proteinas vinculantes que comprenden al menos dos dominios de repeticion contra her2.
MX340556B (es) Anticuerpos biespecificos activables.
MY163539A (en) Antibody fc variants
MX2018010572A (es) Inmunoglobulinas heterodimericas.
EP2560684A4 (en) FIBRONECTIN TYPE III DOMAIN MULTIMERIC SCAFFOLDS
WO2014160160A3 (en) Antibody drug conjugates and corresponding antibodies
WO2013184939A3 (en) Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide
MX2014012978A (es) Regiones de anticuerpo modificado y sus usos.
MX359449B (es) Conjugados de anticuerpo fármaco anti-cd70.
MX2015012872A (es) Anticuerpos anti-tau y metodos de uso.
MX2013013832A (es) Proteínas de unión receptoras fc.
PH12016500123A1 (en) Therapeutic fusion protein
MX2016000611A (es) Fusocinas que implican citocinas con una afinidad de union al receptor considerablemente menor.
NZ629553A (en) Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof
PH12015500752A1 (en) Her3 antigen binding proteins binding to the beta-hairpin of her3
MX2015000754A (es) Proteinas de btnl3, acidos nucleicos, y anticuerpos y los usos de los mismos.
PH12015500751A1 (en) Anti-her3/her4 antigen binding proteins binding to the beta-hairpin of her3 and beta-hairpin of her4
PH12016500826A1 (en) Anti-ccl17 antibodies
EP2928492A4 (en) Hiv-1 envelope proteins and fragments thereof that possess epitopes recognized by broadly neutralizing antibodies
MX2013011596A (es) Anticuerpos que se unen a tgf-alfa y epiregulina.

Legal Events

Date Code Title Description
FG Grant or registration